PHARMACOKINETICS OF BRIVARACETAM IN SUBJECTS WITH SEVERE RENAL IMPAIRMENT

被引：0
|
作者：
Stockis, A. [1 ]
Jacobs, T. [1 ]
Leonard, M. [1 ]
Sargentini-Maier, M. L. [1 ]
机构：
[1] UCB Pharma SA, Braine Lalleud, Belgium
来源：
EPILEPSIA | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [1] The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment
    Jin, Feng
    Robeson, Michelle
    Zhou, Huafeng
    Hisoire, Grace
    Ramanathan, Srini
    CANCER RESEARCH, 2014, 74 (19)
  • [2] The Pharmacokinetics and Safety Of Idelalisib In Subjects With Severe Renal Impairment
    Jin, Feng
    Robeson, Michelle
    Zhou, Huafeng
    Hisoire, Grace
    Ramanathan, Srini
    BLOOD, 2013, 122 (21)
  • [3] The pharmacokinetics and safety of darapladib in subjects with severe renal impairment
    Magee, Mindy He
    Shaddinger, Bonnie
    Collins, David
    Siddiqi, Shabana
    Soffer, Joseph
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 654 - 661
  • [4] The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment
    F. Jin
    M. Robeson
    H. Zhou
    G. Hisoire
    S. Ramanathan
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1133 - 1141
  • [5] Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
    Min, K. Chris
    Lasseter, Kenneth C.
    Marbury, Thomas C.
    Wrishko, Rebecca E.
    Hanley, William D.
    Wolford, Dennis G.
    de Haes, Joanna Udo
    Reitmann, Christina
    Gutstein, David E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (09) : 746 - 752
  • [6] The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment
    Jin, F.
    Robeson, M.
    Zhou, H.
    Hisoire, G.
    Ramanathan, S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1133 - 1141
  • [7] Pharmacokinetics and pharmacodynamics of tonapofylline in subjects with severe renal impairment and in elderly subjects
    Li, Z.
    TenHoor, C.
    Marbury, T.
    Swan, S.
    Zhu, Y.
    Ticho, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (09) : 563 - 570
  • [8] PHARMACOKINETICS OF BRIVARACETAM IN SUBJECTS WITH HEPATIC IMPAIRMENT AND IN MATCHED HEALTHY CONTROLS
    Stockis, Armel
    Sargentini-Maier, Maria Laura
    Boulton, M.
    Horsmans, Y.
    EPILEPSIA, 2008, 49 : 457 - 457
  • [9] PHARMACOKINETICS OF BRIVARACETAM IN SUBJECTS WITH HEPATIC IMPAIRMENT AND IN MATCHED HEALTHY CONTROLS
    Horsmans, Y.
    Sargentini-Maier, M.
    Stockis, A.
    EPILEPSIA, 2009, 50 : 113 - 113
  • [10] Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment
    Stephen Weller
    Julie Borland
    Shuguang Chen
    Mark Johnson
    Paul Savina
    Brian Wynne
    Toshihiro Wajima
    Amanda F. Peppercorn
    Stephen C. Piscitelli
    European Journal of Clinical Pharmacology, 2014, 70 : 29 - 35
12345